Global Cord Blood Corporation (CORBF) Financials

CORBF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2022 201.1 million 86.0 million
March 31, 2022 1.3 billion 574.9 million
Dec. 31, 2021 1.3 billion 568.2 million
Sept. 30, 2021 1.3 billion 559.3 million

CORBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2022 -48856 ?
March 31, 2022 25.5 million ?
Dec. 31, 2021 ? ?
Sept. 30, 2021 ? ?

CORBF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2022 -48856
March 31, 2022 16.5 million
Dec. 31, 2021 21.1 million
Sept. 30, 2021 19.5 million

CORBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2022 157.0 million - -
March 31, 2022 1.0 billion - 23154
Dec. 31, 2021 1.0 billion - 266763
Sept. 30, 2021 991.5 million - 267635

CORBF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2022 398.9 million
March 31, 2022 19.2 million
Dec. 31, 2021 19.0 million
Sept. 30, 2021 18.9 million

CORBF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2022 - 714169 7.3 million 8.9 million
March 31, 2022 - 752915 7.7 million 9.4 million
Dec. 31, 2021 - 1.1 million 7.5 million 10.4 million
Sept. 30, 2021 - 864656 6.9 million 8.8 million

CORBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2022 44.4 million 6.3 million
March 31, 2022 46.8 million 6.6 million
Dec. 31, 2021 49.9 million 7.4 million
Sept. 30, 2021 48.7 million 7.2 million

CORBF

Price: $0.95

52 week price:
0.20
1.75

Earnings Per Share: 0.35 USD

P/E Ratio: 2.71

Exchange: OEM

Sector: Healthcare

Industry: Diagnostics & Research

Country: Hong Kong

Market Capitalization: 127.4 million

Links: